Skip to content

Asset turnover at other companies

IAR
Integra LifeSciencesIART
0.4×0.0×
MiMedx Group logo
MiMedx GroupMDXG
1.3×-0.1×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
0.0×
Bioventus logo
BioventusBVS
0.9×+0.1×
Artivion logo
ArtivionAORT
0.5×+0.1×
Axogen logo
AxogenAXGN
0.0×

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

Based on trailing twelve months.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s asset turnover?
Organogenesis Holdings Inc. (ORGO) reported asset turnover of 1× in Q1 2026.
How has Organogenesis Holdings Inc.'s asset turnover changed year-over-year?
Organogenesis Holdings Inc.'s asset turnover increased by 5.2% year-over-year, from 1× to 1×.
What is the long-term trend for Organogenesis Holdings Inc.'s asset turnover?
Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s asset turnover has grown at a -4.9% compound annual growth rate (CAGR), from 1.3× to 1×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.